Internship
System Software Engineer Intern
Confirmed live in the last 24 hours
Noah Medical
201-500 employees
Develops medical robotic solutions for diagnostics
Compensation Overview
$24 - $30/hr
No H1B Sponsorship
San Carlos, CA, USA
The job is onsite in San Carlos, California, and does not offer remote work for this position.
Upload your resume to see how it matches 8 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
- Recent graduate with a BS degree in Computer Science, Computer Engineering, or related field OR in the final year of a BS degree in above listed fields
- Proficiency in one or more programming languages, with preference for C\C++\C# or Python
- Understanding of the basic principles of software design, including object-oriented programming, data structures, and algorithms
- Experience with software development tools like source control (git) and IDEs
- Self-motivated individual that works well in a team environment
- Good verbal and written communication and documentation skills
- Fast learner willing to gain exposure to multiple new systems, software tools, and technologies
- Work collaboratively across cross-functional teams in a start-up environment with minimal supervision and guidance
- Contribute to the design and development process of software for a robotic platform and its subsystems
- Understand requirements and specifications in order to write quality software and software unit tests that verify these requirements are met
- Troubleshoot and seek to understand technical issues as they arise in the software development process, and communicate these issues and potential solutions with the system software engineering team
Noah Medical creates medical robotic solutions to improve early diagnosis in pulmonology. Their main product, the Galaxy System™ with TiLT+ Technology™, enhances diagnostic accuracy by providing real-time navigation and guidance in the lungs, along with an augmented fluoro feature to help locate lesions. The system's single-use bronchoscope reduces cross-contamination risks and improves procedural efficiency. Noah Medical differentiates itself by collaborating with leading pulmonologists to refine their technology, aiming to enhance the confidence and accuracy of lung disease diagnosis.
Company Size
201-500
Company Stage
Series B
Total Funding
$150M
Headquarters
Redwood City, California
Founded
2018
Simplify's Take
What believers are saying
- Growing demand for minimally invasive procedures aligns with Noah Medical's focus.
- Rising investment in healthcare technology startups offers funding opportunities for Noah Medical.
- Advancements in AI enhance real-time image processing in Noah Medical's robotic systems.
What critics are saying
- Increased competition from established companies like Intuitive Surgical in robotic bronchoscopy.
- Potential delays in regulatory approvals could impact market entry and sales.
- High cost of the Galaxy System™ may limit adoption in smaller healthcare facilities.
What makes Noah Medical unique
- Noah Medical's Galaxy System™ offers real-time navigation updates for lung procedures.
- The system's single-use bronchoscope reduces cross-contamination and improves procedural efficiency.
- Compact design of the Galaxy System™ suits crowded bronch suites and operating rooms.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Mental Health Support
Legal Services
Pet Insurance
12+ Paid Holidays
15-20 Days of PTO
Paid Parental Leave
In-office Snacks and Beverages
In-office Lunch Stipend
Learning & Development Opportunities
Team Building and Company Organized Social Events
Hybrid Work Options
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 2%2 year growth
↑ 6%MemorialCare Cancer Institute uses first-of-its-kind robotic navigated bronchoscopy for greater precision and accuracy.LAGUNA HILLS, Calif., Aug. 6, 2024 /PRNewswire/ -- MemorialCare Cancer Institute's Lung Cancer Program at Saddleback Medical Center is one of just four hospitals in California equipped with the recently FDA-cleared robotic navigated bronchoscopy system. This new device from NoahMed, Galaxy System, uses integrated tomosynthesis (3D mammography) to navigate to and locate lung nodules, which are small masses in the lungs often tested for cancer.This improved visualization, along with a disposable bronchoscope, enhances precision and accuracy beyond the capabilities of existing technologies. It gives physicians access to often hard-to-reach lesions in the outer third of the lung which are often hard to biopsy. The Galaxy System can biopsy nodules smaller than 2cm, while receiving real-time lesion location updates."Lung cancer is an insidious disease causing far too high a toll on our communities," said Jayne Stewart, executive director, MemorialCare Cancer Institute, MemorialCare Saddleback Medical Center. "The Galaxy System gives physicians trained on the device a clear, direct path to improving patient diagnosis and, in turn, treatment –allowing us to catch lung cancer before it reaches less treatable, advanced stages
Noah MedicalNext-generation robotics company and its CEO recognized separately for pioneering work, innovative new technology, and rapid progressSAN CARLOS, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical announced today that it has been named a finalist in the prestigious Surgical Robotics Industry Awards 2024 alongside its founder and CEO Dr. Jian Zhang. This joint recognition highlights Noah Medical’s groundbreaking work in endoluminal robotics and Dr. Zhang’s visionary leadership within the industry.Noah Medical is a finalist in the Innovative Start-up category, which honors companies under six years old that have demonstrated significant potential and introduced innovative solutions to enhance surgical procedures and patient outcomes. Dr. Zhang is a finalist in the Industry Leadership category, awarded to those who have demonstrated outstanding business or commercial success, highly effective management, and a track record as a thought leader.Since the beginning of 2023, Noah Medical has announced $150 million in Series B funding , secured FDA clearance for The Galaxy System™, its fully image-integrated solution for robotic navigated bronchoscopy, and launched the platform to commercial and industry acclaim.The company’s proprietary technology is transforming the early identification and diagnosis of lung cancer by making it possible for physicians to overcome traditional imaging and navigation limitations to confidently reach nodules in the outer periphery of the lung
Listen to this articleNoah Medical’s Galaxy is a fully integrated surgical robotics system for navigated bronchoscopy. | Credit: Noah Medical. Medical robotics continues its impressive march forward within mainstream medicine. From new applications to new technologies, the field demonstrated impressive growth over the last year. But there’s still incredible room to grow, and looking ahead to 2024, there are a few clear areas of opportunity
SAN CARLOS, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical announced today that its Galaxy System, a fully image-integrated solution for robotic navigated bronchoscopy, was named a finalist in the 2023 Fierce Innovation Awards: Life Sciences Edition. The Galaxy System was recognized in the Medical Device Innovation category for its groundbreaking combination of innovative new technologies and features, including proprietary integrated tomosynthesis with augmented fluoroscope, a disposable single-use scope, and small footprint.Fierce Innovation Awards showcase innovations that have made an impact over the last 12 months and represent the greatest potential to transform the industry. The Galaxy System is the first of its kind and was built from the ground up based on physician feedback about the complex and life-altering decisions made during a lung biopsy procedure. With the introduction of the Galaxy System, more physicians in a broader range of clinical settings can diagnose disease earlier, ensuring patients can receive appropriate treatment at an earlier stage of the disease.“This award is a recognition of the entire team at Noah Medical, our commitment to revolutionizing medical robotics, and our work helping patients live better, healthier lives,” said Noah Medical CEO Jian Zhang. “We are honored to be praised by experts and peers within the industry for our work, we are transforming patient experiences and redefining the future of healthcare.”The Galaxy System’s “Tool-in-Lesion Tomography” or “TiLT” Technology was designed to overcome CT-to-body divergence by providing real-time lesion updates during a bronchoscopy procedure
Noah Medical’s Galaxy System is used in the US for the first time. By Brianna Wessling | May 22, 2023Listen to this articleVIDEO. Noah Medical announced that its Galaxy System, an integrated system for navigated robotic bronchoscopy, was used for the first time in the United States at the University of Chicago Medicine by Dr. Kyle Hogarth.